https://www.selleckchem.com/pr....oducts/bay-2666605.h
To better understand the healthcare burden of people with type 2 diabetes (T2D) and estimated glomerular filtration rate (eGFR) 90 mL/min/1.73 m in Ontario, Canada. We used administrative data to evaluate the prevalence of T2D, eGFR 90 mL/min/1.73 m and adverse cardiovascular co-morbidities in individuals aged ≥ 30 years living in Ontario, Canada. We also examined incremental healthcare costs and healthcare resource utilization (HCRU) for these patients with specific incident cardiovascular and renal outcomes, in compariso